Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma

Hypertension

Volumn 60, Issue 2, 2012, Pages 431-436

  Rossi, Gian Paolo ^a   Ragazzo, Fabio ^a   Seccia, Teresa Maria ^a   Maniero, Carmela ^a   Barisa, Marlena ^a   Calò, Lorenzo A ^a   Frigo, Anna Chiara ^c   Fassina, Ambrogio ^b   Pessina, Achille Cesare ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b Department of Cardiac Thoracic and Vascular Sciences ^*  (Italy)

^c UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

aldosterone; aldosterone producing adenoma; calcium; diagnosis; endocrine hypertension; mineralocorticoids; PTH; secondary hypertension

Indexed keywords

ALDOSTERONE; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; RENIN;

ADRENAL HYPERPLASIA; ADRENALECTOMY; ADULT; ARTICLE; CALCIUM METABOLISM; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; ESSENTIAL HYPERTENSION; FOLLOW UP; HUMAN; HYPERPARATHYROIDISM; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADRENAL CORTEX NEOPLASMS; ADRENAL GLANDS; ADRENOCORTICAL ADENOMA; ADULT; ALDOSTERONE; CALCIUM; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERALDOSTERONISM; HYPERPARATHYROIDISM; HYPERPLASIA; HYPERTENSION; MIDDLE AGED; PARATHYROID HORMONE; PROSPECTIVE STUDIES; RENIN;

EID: 84864284118     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.195891     Document Type: Article

References (27)

1. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM, for the Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266-3281.
2. Resnick LM, Laragh JH. Calcium metabolism and parathyroid function in primary aldosteronism. Am J Med. 1985;78:385-390. (Pubitemid 15107917)
3. Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Am J Hypertens. 1995;8:884-893.
4. Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V, McMahon DJ. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med. 1997;103:197-207. (Pubitemid 27413402)
5. Alsafwah S, Laguardia SP, Arroyo M, Dockery BK, Bhattacharya SK, Ahokas RA, Newman KP. Congestive heart failure is a systemic illness: A role for minerals and micronutrients. Clin Med Res. 2007;5:238-243. (Pubitemid 351731693)
6. Weber KT, Gerling IC, Kiani MF, Guntaka RV, Sun Y, Ahokas RA, Postlethwaite AE, Warrington KJ. Aldosteronism in heart failure: A proinflammatory/fibrogenic cardiac phenotype-search for biomarkers and potential drug targets. Curr Drug Targets. 2003;4:505-516. (Pubitemid 36869223)
7. Maniero C, Fassina A, Seccia TM, Toniato A, Iacobone M, Plebani M, De Caro R, Calo LA, Pessina AC, Rossi GP. Mild hyperparathyroidism: A novel surgically correctable feature of primary aldosteronism. J Hypertens. 2012;30:390-395.
8. Pilz S, Kienreich K, Drechsler C, Ritz E, Fahrleitner-Pammer A, Gaksch M, Meinitzer A, Marz W, Pieber TR, Tomaschitz A. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH Study. J Clin Endocrinol Metab. 2012; 97:E75-E79.
9. Tomaschitz A, Ritz E, Pieske B, Fahrleitner-Pammer A, Kienreich K, Horina JH, Drechsler C, Marz W, Ofner M, Pieber TR, Pilz S. Aldosterone and parathyroid hormone: A precarious couple for cardiovascular disease. Cardiovasc Res. 2012;94:10-19.
10. Rossi GP. Hyperparathyroidism, arterial hypertension and aortic stiffness: A possible bidirectional link between the adrenal cortex and the parathyroid glands that causes vascular damage? Hypertens Res. 2011;34: 286-288.
11. Rafferty B, Zanelli JM, Rosenblatt M, Schulster D. Corticosteroidogenesis and adenosine 3=, 5=-monophosphate production by the aminoterminal (1-34) fragment of human parathyroid hormone in rat adrenocortical cells. Endocrinology. 1983;113:1036-1042. (Pubitemid 13051948)
12. Rosenberg J, Pines M, Hurwitz S. Response of adrenal cells to parathyroid hormone stimulation. J Endocrinol. 1987;112:431-437. (Pubitemid 17020880)
13. Hanley NA, Wester RM, Carr BR, Rainey WE. Parathyroid hormone and parathyroid hormone-related peptide stimulate aldosterone production in the human adrenocortical cell line, NCI-H295. Endocrine J. 1993;1: 447-450. (Pubitemid 2021559)
14. Isales CM, Barrett PQ, Brines M, Bollag W, Rasmussen H. Parathyroid hormone modulates angiotensin II-induced aldosterone secretion from the adrenal glomerulosa cell. Endocrinology. 1991;129:489-495.
15. Mazzocchi G, Aragona F, Malendowicz LK, Nussdorfer GG. PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells. Am J Physiol Endocrinol Metab. 2001;280:E209-E213.
16. Rizk-Rabin M, Assie G, Rene-Corail F, Perlemoine K, Hamzaoui H, Tissier F, Lieberherr M, Bertagna X, Bertherat J, Bouizar Z. Differential expression of parathyroid hormone-related protein in adrenocortical tumors: autocrine/paracrine effects on the growth and signaling pathways in H295R cells. Cancer Epidemiol Biomarkers Prev. 2008;17:2275-2285.
17. Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z, Smith RA, Gerling IC, Weber KT. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation. 2005;111:871-878. (Pubitemid 40279888)
18. Brunaud L, Germain A, Zarnegar R, Rancier M, Alrasheedi S, Caillard C, Ayav A, Weryha G, Mirallie E, Bresler L. Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism. Surgery. 2009;146:1035-1041.
19. Rossi GP, Boscaro M, Ronconi V, Funder JW. Aldosterone as a cardiovascular risk factor. Trends Endocrinol Metab. 2005;16:104-107. (Pubitemid 40432459)
20. Funder JW. Is aldosterone bad for the heart? Trends Endocrinol Metab. 2004;15:139-142. (Pubitemid 38510491)
21. Rossi GP. A comprehensive review of the clinical aspects of primary aldosteronism. Nat Rev Endocrinol. 2011;7:485-495.
22. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F, for the PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006; 48:2293-2300. (Pubitemid 44873058)
23. Obuchowski NA. Sample size calculations in studies of test accuracy. Stat Methods Med Res. 1998;7:371-392. (Pubitemid 28559255)
24. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-843. (Pubitemid 13033817)
25. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG, for the Standards for Reporting of Diagnostic Accuracy. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003;138:W1-W12.
26. Rossi G, Barisa M, Auchus R, Amar L, Cohen D, Deinum J, Kline G, Lacroix A, Lang K, Magill S, Naruse M, Omura M, Quinkler M, Reincke M, Rossi E, Rump L, Satoh F, Stowasser M, Tanabe A, Widimsky J, Wu K. The adrenal vein sampling international study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab. 2012;97:1606-1614.
27. Rossi E, Perazzoli F, Negro A, Sani C, Davoli S, Dotti C, Casoli MC, Regolisti G. Acute effects of intravenous sodium chloride load on calcium metabolism and on parathyroid function in patients with primary aldosteronism compared with subjects with essential hypertension. Am J Hypertens. 1998;11:8-13. (Pubitemid 28083146)